当前位置:首页 - 行情中心 - 莲花健康(600186) - 财务分析 - 利润表

莲花健康

(600186)

  

流通市值:75.90亿  总市值:76.24亿
流通股本:17.86亿   总股本:17.94亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入1,614,339,467.07973,641,658.36455,779,558.551,691,055,172.21
营业收入1,614,339,467.07973,641,658.36455,779,558.551,691,055,172.21
二、营业总成本1,486,653,216.71905,133,259.15427,154,766.871,602,812,611.39
营业成本1,343,746,579.25814,604,933.52384,004,538.431,452,485,235.39
税金及附加7,984,127.094,854,282.392,405,794.9910,202,008.71
销售费用79,663,811.4449,312,798.124,101,922.8768,970,559.94
管理费用56,407,696.6537,562,779.9516,944,209.0562,751,224.45
研发费用14,240,968.988,406,590.853,183,767.5521,557,179.52
财务费用-15,389,966.7-9,608,125.66-3,485,466.02-13,153,596.62
其中:利息费用192,000192,000144,0005,094,275.64
其中:利息收入12,971,868.957,238,042.644,880,088.7716,724,403.19
加:投资收益-595,932.55-401,299.55-183,896.28-955,349.92
资产处置收益-1,206,979.1-1,206,979.1--
资产减值损失(新)----1,153,086.45
信用减值损失(新)-634,259.97-752,620.86--4,434,969.2
其他收益552,200312,200-610,700
营业利润平衡项目0000
四、营业利润125,801,278.7466,459,699.728,440,895.482,309,855.25
加:营业外收入2,912,612.991,163,662.391,149,546.51669,442.24
减:营业外支出693,668.55197,0001,206,979.122,585,432.61
利润总额平衡项目0000
五、利润总额128,020,223.1867,426,362.0928,383,462.8160,393,864.88
减:所得税费用31,176,719.9115,295,256.786,346,315.6313,417,237.43
六、净利润96,843,503.2752,131,105.3122,037,147.1846,976,627.45
持续经营净利润96,843,503.2752,131,105.3122,037,147.1846,976,627.45
归属于母公司股东的净利润94,592,755.0550,159,566.0520,987,154.1646,167,166.21
少数股东损益2,250,748.221,971,539.261,049,993.02809,461.24
(一)基本每股收益0.050.030.010.03
(二)稀释每股收益0.050.030.010.03
八、其他综合收益---16,165.77
归属于母公司股东的其他综合收益---16,165.77
九、综合收益总额96,843,503.2752,131,105.3122,037,147.1846,992,793.22
归属于母公司股东的综合收益总额94,592,755.0550,159,566.0520,987,154.1646,183,331.98
归属于少数股东的综合收益总额2,250,748.221,971,539.261,049,993.02809,461.24
公告日期2023-10-162023-08-312023-04-292023-03-31
审计意见(境内)标准无保留意见
TOP↑